Aquestive Therapeutics, Inc. (AQST) vs Fulgent Genetics, Inc. (FLGT)
A side-by-side comparison of Aquestive Therapeutics, Inc. and Fulgent Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AQST
Aquestive Therapeutics, Inc.
$4.58HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
FLGT
Fulgent Genetics, Inc.
$20.89HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — AQST vs FLGT
growth of $100 · dividends reinvested · last 8yAQST -71.5% (-14.5%/yr)FLGT +361.9% (+21.1%/yr)FLGT compounded faster over this window
Log scale — wide-divergence pair
AQST FLGT
AQST vs FLGT: by the numbers
- •FLGT is the larger company ($593M vs $574M market cap).
- •Both run net losses; FLGT's is the smaller (-26.05% vs -144.63% net margin).
- •Both shrank revenue over the past five years; AQST's decline was smaller (-0.58% vs -18.66% CAGR).
Metrics side by side
Valuation
| Metric | AQST | FLGT |
|---|---|---|
| P/S ratio | 10.61 | 1.83 |
| P/B ratio | N/A | 0.59 |
Profitability
| Metric | AQST | FLGT |
|---|---|---|
| Gross margin | 67.04% | 35.58% |
| Operating margin | -156.36% | -28.23% |
| Net margin | -144.63% | -26.05% |
| ROE | N/A | -8.42% |
| ROIC | -45.62% | -11.80% |
Growth (annualized)
| Metric | AQST | FLGT |
|---|---|---|
| Revenue CAGR (5Y) | -0.58% | -18.66% |
| Total return CAGR (5Y) | 2.24% | -22.38% |
Frequently asked
- Which has grown faster, AQST or FLGT?
- Neither grew: over the past five years both shrank revenue, with AQST's decline the smaller — AQST at a -0.58% CAGR versus FLGT at -18.66%.
- How have AQST and FLGT total returns compared?
- Over the past 5 years, AQST delivered 2.24% and FLGT delivered -22.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.